Advocacy Visibility Index (AVI)

Please rate each statement on a scale from Strongly Disagree (1) to Strongly Agree (5).

Our advocacy insights have directly influenced access, clinical trial design, or patient services. *

Strategic Risk Score

Please rate each statement on a scale from Strongly Disagree (1) to Strongly Agree (5).

We have a dedicated patient advocacy budget line item—we’re not funded ad hoc or through other departments. *

The Executive leadership team has prioritized patient engagement and advocacy as a business focus. *

We are always consulted before any patient-facing decisions are made. We never find out about patient-facing decisions after they’ve been made. *

The value of Patient Advocacy and Engagement is clearly understood in quantitative or financial terms by senior leadership. *

Patient Advocacy & Engagement is seen as having quantifiable and qualifiable value to the organization. It is not seen as "soft" value or PR for our organization. *

We do not have budget requests rejected. If we do get rejections, we are offered alternative paths for success. *

Our wins are viewed as quantifiable and wins that change the outcome for our company, rather than anecdotal 'nice to have' wins. *